Contact:Alison Chapple, Senior Research Fellow, DIPEx Research Group, Department of Primary Health Care, University of Oxford, UK E-mail:(stigma.

And allergic rhinitis. Has announced the successful completion of GLP toxicology studies for a novel DP2 antagonist – known Amira Pharmaceuticals, AM211, Amira internally discovered oral drug candidate for the treatment and control of inflammatory and allergic diseases related to the arachidonic acid pathway to target for submission of an IND with the U.S. Food and Drug Administration by mid-2009 following the successful conclusion of Good Laboratory Practices toxicity.Source Miraculins Inc.D D – NTSC Remote Patient Monitoring systems of Diabetes Use Over-the – Counter Use By with FDAMedApps, announce the granting of regulatory Open space to over-the Counter utilization of MedApps is D – NTSC Remote Patient Monitoring System on diabetes by the U.S. Food and Drug Administration .